Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth.

作者: Fiona A Mack , W.Kimryn Rathmell , Andrew M Arsham , James Gnarra , Brian Keith

DOI: 10.1016/S1535-6108(02)00240-4

关键词: Hypoxia-Inducible Factor 1Internal medicineTranscription factorApoptosisHypoxia-inducible factorsCell biologyDNA-binding proteinEndocrinologyBiologyProtein subunitCarcinogenesisNuclear protein

摘要: Inactivation of the von Hippel-Lindau (VHL) gene is associated with development highly vascularized tumors. pVHL targets alpha subunits hypoxia inducible factor (HIF) for ubiquitin-mediated degradation in an oxygen-dependent manner. Although pVHL-deficient tumor cell lines demonstrate constitutive stabilization and activation HIF, it has yet to be shown that loss murine Vhl alone sufficient dysregulate HIF. We utilized a genetic approach not only stabilize HIF-alpha under normoxia, but also fully activate HIF-mediated responses. These studies have implications hierarchy signaling events leading HIF stabilization, nuclear translocation, target expression. further does promote teratocarcinoma growth, indicating other changes must occur facilitate Vhl-mediated tumorigenesis.

参考文章(63)
Antonio D. Cristofano, Barbara Pesce, Carlos Cordon-Cardo, Pier P. Pandolfi, Pten is essential for embryonic development and tumour suppression. Nature Genetics. ,vol. 19, pp. 348- 355 ,(1998) , 10.1038/1235
Andrew L. Kung, Stream Wang, Jeffery M. Klco, William G. Kaelin, David M. Livingston, Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nature Medicine. ,vol. 6, pp. 1335- 1340 ,(2000) , 10.1038/82146
Masayuki Kamada, Taro Shuin, Heiwa Okuda, Yasumasa Kato, Keiji Suzuki, von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility. Cancer Research. ,vol. 61, pp. 4184- 4189 ,(2001)
Peter Carmeliet, Yuval Dor, Jean-Marc Herbert, Dai Fukumura, Koen Brusselmans, Mieke Dewerchin, Michal Neeman, Françoise Bono, Rinat Abramovitch, Patrick Maxwell, Cameron J. Koch, Peter Ratcliffe, Lieve Moons, Rakesh K. Jain, Désiré Collen, Eli Keshet, Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. ,vol. 394, pp. 485- 490 ,(1998) , 10.1038/28867
Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang, Steven C. Clifford, Emma C. Vaux, Matthew E. Cockman, Charles C. Wykoff, Christopher W. Pugh, Eamonn R. Maher, Peter J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature. ,vol. 399, pp. 271- 275 ,(1999) , 10.1038/20459
Kim M. Lonergan, Othon Iliopoulos, Michael Ohh, Takumi Kamura, Ronald C. Conaway, Joan Weliky Conaway, William G. Kaelin, Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2 Molecular and Cellular Biology. ,vol. 18, pp. 732- 741 ,(1998) , 10.1128/MCB.18.2.732
J. Lisztwan, G. Imbert, C. Wirbelauer, M. Gstaiger, W. Krek, The von Hippel–Lindau tumor suppressor protein is a component of an E3 ubiquitin–protein ligase activity Genes & Development. ,vol. 13, pp. 1822- 1833 ,(1999) , 10.1101/GAD.13.14.1822
Christopher W. Pugh, John F. O'Rourke, Masaya Nagao, Jonathan M. Gleadle, Peter J. Ratcliffe, Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit Journal of Biological Chemistry. ,vol. 272, pp. 11205- 11214 ,(1997) , 10.1074/JBC.272.17.11205
Keiji Tanimoto, Yuichi Makino, Teresa Pereira, Lorenz Poellinger, Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein The EMBO Journal. ,vol. 19, pp. 4298- 4309 ,(2000) , 10.1093/EMBOJ/19.16.4298
David Lando, Daniel J Peet, Dean A Whelan, Jeffrey J Gorman, Murray L Whitelaw, Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. ,vol. 295, pp. 858- 861 ,(2002) , 10.1126/SCIENCE.1068592